Relmada Therapeutics Company Profile (OTC:RLMDD)

About Relmada Therapeutics

Relmada Therapeutics logo

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTC
  • Symbol: RLMDD
  • CUSIP:
Key Metrics:
  • Previous Close: $4.72
  • 50 Day Moving Average: $3.11
  • 200 Day Moving Average: $5.64
  • 52-Week Range: $2.00 - $19.90
  • Trailing P/E Ratio: 9.22
  • Foreward P/E Ratio: -2.24
  • P/E Growth: 0.00
  • Market Cap: $56.64M
Additional Links:

Analyst Ratings

Consensus Ratings for Relmada Therapeutics (OTC:RLMDD) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Relmada Therapeutics (OTC:RLMDD)
Show:
DateFirmActionRatingPrice TargetDetails
9/3/2015FBR & CoInitiated CoverageMarket Perform$7.00View Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for Relmada Therapeutics (OTC:RLMDD)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Relmada Therapeutics (OTC:RLMDD)
Current Year EPS Consensus Estimate: $-1.40 EPS
Next Year EPS Consensus Estimate: $-2.11 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.44)($0.44)($0.44)
Q2 20161($0.45)($0.45)($0.45)
Q4 20161($0.18)($0.18)($0.18)
Q1 20171($0.16)($0.16)($0.16)
Q2 20171($0.18)($0.18)($0.18)
Q3 20171($0.18)($0.18)($0.18)
Q4 20171($0.18)($0.18)($0.18)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Relmada Therapeutics (OTC:RLMDD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Relmada Therapeutics (OTC:RLMDD)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headlines for Relmada Therapeutics (OTC:RLMDD)
No headlines for this company have been tracked by MarketBeat.com

Social

What is Relmada Therapeutics' stock symbol?

Relmada Therapeutics trades on the OTC under the ticker symbol "RLMDD."

How do I buy Relmada Therapeutics stock?

Shares of Relmada Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Relmada Therapeutics stock cost?

One share of Relmada Therapeutics stock can currently be purchased for approximately $4.72.


Last Updated on 2/25/2017 by MarketBeat.com Staff